|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivables, net of allowance of $1,473 and $448, respectively | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment: | ||||||||||||||||||||
| Unproved | ||||||||||||||||||||
| Proved | ||||||||||||||||||||
| Total oil and natural gas properties | ||||||||||||||||||||
| Less: accumulated depreciation, depletion, amortization and impairment | ||||||||||||||||||||
| Oil and natural gas properties, full cost method of accounting, net | ||||||||||||||||||||
| Other property and equipment, net | ||||||||||||||||||||
| Total property and equipment, net | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Debtor in-possession facility | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities and other | ||||||||||||||||||||
| Revenue payable | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Term loan - Heartland, net of discount | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Long-term derivative instruments and other non-current liabilities | ||||||||||||||||||||
| Long-term deferred revenue liabilities | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Long-term lease liabilities | ||||||||||||||||||||
| Long-term deferred revenue and other liabilities | ||||||||||||||||||||
| Total liabilities not subject to compromise | ||||||||||||||||||||
| Liabilities subject to compromise | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity (deficit): | ||||||||||||||||||||
| Series B Preferred stock, $0.0001 par value; stated value of $1,000; 20,000 shares authorized; 16,828 shares issued and outstanding at December 31, 2016, with a liquidation preference of $20,627 at December 31, 2016 | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Common stock, $0.0001 par value per share; 150,000,000 shares authorized 95,097,919 and 91,584,460 issued and outstanding as of September 30, 2020 and December 31, 2019, respectively, of which 253,598 shares are being held in treasury stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, 253,598 shares at cost | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Total stockholders’ equity (deficit) | ||||||||||||||||||||
| Total liabilities, mezzanine equity and stockholders’ equity (deficit) | ||||||||||||||||||||
| Mezzanine equity: | ||||||||||||||||||||
| Series C-1 Preferred Stock | ||||||||||||||||||||
| Series C-2 Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Series F Preferred Stock | ||||||||||||||||||||
| Total mezzanine equity: | ||||||||||||||||||||
Loading...